Microelectrode Array In Vitro Market Scope And Analysis

  • Report Code : TIPRE00024001
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 197
Buy Now

Microelectrode Array in Vitro Market Size and Scope by 2031

Buy Now

Microelectrode Array in Vitro Market Report Microelectrode Array in Vitro Market Size and Share Microelectrode Array in Vitro Market Scope and Analysis

Microelectrode Array in Vitro Market Report Scope

Report Attribute Details
Market size in 2023 US$ 17.96 Million
Market Size by 2031 US$ 25.67 Million
Global CAGR (2023 - 2031) 4.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Classical MEA
  • Multiwell-MEA
  • CMOS-ME
By Application
  • Cardiomyocytes
  • Nerve
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Tucker Davis Technologies
  • Screen Holdings Co Ltd
  • Plexon Inc
  • Neuronexus
  • Neuralynx Inc
  • MaxWell Biosystems AG
  • Harvard Bioscience Inc
  • Blackrock Microsystems LLC
  • Axion BioSystems Inc

    • Microelectrode Array in Vitro Market News and Recent Developments

    The microelectrode array in vitro market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

    • Axion BioSystems and STEMCELL Technologies entered a strategic partnership that will enable STEMCELL to sell Axion’s state-of-the-art Maestro Pro and Maestro Edge multielectrode array systems within North America and Europe. The industry-leading Maestro MEA systems will also continue to be available for purchase worldwide directly from Axion BioSystems. (Source: Axion BioSystems, Company Website, September 2024).
    • NETRI launched an MEA-capable organs-on-chip line, NeuroFluidics MEA, composed of three compartmentalized microfluidic devices powered by Axion Biosystems' integrated MEA technology and compatible with Maestro Pro and Maestro Edge systems. (Source: Axion BioSystems, Company Website, July 2023)

    Microelectrode Array in Vitro Market Report Coverage and Deliverables

    The "Microelectrode Array in Vitro Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Microelectrode array in vitro market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Microelectrode array in vitro market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Microelectrode array in vitro market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the microelectrode array in vitro market
    • Detailed company profiles